Home › Business & Finance › City Therapeutics Raises $200 Million in Upsized US IPO
Business & Finance

City Therapeutics Raises $200 Million in Upsized US IPO

Key Points

City Therapeutics Inc., an early-stage developer of RNAi-based drugs, raised $200 million in a US initial public offering priced at the mid-point of its marketed range.

City Therapeutics Inc., an early-stage developer of RNAi-based drugs, raised $200 million in a US initial public offering priced at the mid-point of its marketed range.
City Therapeutics (ORG) Upsized US IPO City Therapeutics Inc. (ORG) US (LOCATION)
Originally published by Bloomberg Markets Read original →